Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-31 Henderson Molly Chief Financial Officer Grant or award · Restricted Stock Units +7,500 7,500
2022-01-31 Henderson Molly Chief Financial Officer Grant or award · Stock Option (right to buy) +30,000 30,000
2022-01-31 Schoenberg Mark Chief Medical Officer Exercise or conversion +500 22,595
2022-01-31 Schoenberg Mark Chief Medical Officer Sale −275 $7.58 $2K 22,320
2022-01-31 Schoenberg Mark Chief Medical Officer Exercise or conversion +2,000 24,320
2022-01-31 Schoenberg Mark Chief Medical Officer Sale −1,099 $7.58 $8K 23,221
2022-01-31 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −500 2,000
2022-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Stock Option (right to buy) +12,064 12,064
2022-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +4,000 4,000
2022-01-31 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock −2,000 4,000
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +5,000 303,220
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Sale −2,235 $7.58 $17K 300,985
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +13,333 314,318
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Sale −5,960 $7.58 $45K 308,358
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −5,000 5,000
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −13,333 26,667
2022-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2022-01-26 Schoenberg Mark Chief Medical Officer Exercise or conversion +209 22,206
2022-01-26 Schoenberg Mark Chief Medical Officer Sale −111 $8.09 $898 22,095
2022-01-26 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −209 0

Page 14 of 25 · 496 trades